Additionally, regulatory approvals for drugs such as semaglutide (Wegovy) specifically for obesity treatment have expanded the patient population significantly
Consultare prima il proprio medico di fiducia in questo caso
At the highest dose studied (12mg), 100% of participants achieved at least 5% weight loss and 26% achieved more than 30% weight loss, figures not seen with any previously studied compound in this class
In contrast, when analyzing stroke outcomes, the effect was more pronounced with GLP-1 RAs, which provided the greatest contribution to the reduction of stroke events
PATCHWORK OF LAWS: Houston-based Empower Pharmacys drugs raised red flags for FDA and other states, but not Texas Some states are developing their own laws to protect patients from poorly made GLP-1s, but the broader federal safeguards implemented by Congress 13 years ago remain in limbo